{"id":"W4404520549","doi":"10.1016/j.fpurol.2024.07.039","title":"Nivolumab plus ipilimumab (NIVO+IPI) vs sunitinib (SUN) dans le traitement de première ligne (1L) du carcinome rénal avancé (CCRa) : données de suivi à long terme de l’étude de phase 3 CheckMate 214","year":2024,"lang":"fr","type":"article","venue":"Progrès en Urologie - FMC","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ipilimumab; Medicine; Cancer research; Immunotherapy; Cancer; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.003410101,0.001505004,0.001615327,0.0005599,0.0005355832,0.000567448,0.001180445,0.001046292,0.0006558358],"category_scores_gemma":[0.0006482319,0.001488993,0.0008664031,0.0007303755,0.0009547415,0.0006001962,0.0006267959,0.001835331,0.0002980985],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008557509,"about_ca_system_score_gemma":0.005561681,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002398117,"about_ca_topic_score_gemma":0.001548321,"domain_scores_codex":[0.9892543,0.001427793,0.001484554,0.001912334,0.001005936,0.00491509],"domain_scores_gemma":[0.9953436,0.0009867497,0.0003674048,0.001329386,0.0002473562,0.001725469],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01310926,0.01374199,0.4523,0.01516354,0.006139045,0.07862598,0.06388903,0.00608602,0.1723498,0.003064354,0.003527212,0.1720038],"study_design_scores_gemma":[0.05784694,0.03052606,0.338045,0.004955272,0.01175051,0.02028888,0.007985355,0.1418848,0.3241132,0.002436122,0.05529931,0.004868521],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9325339,0.04559247,0.004986216,0.008231802,0.001284519,0.002881942,0.0002957269,0.001023463,0.003170014],"genre_scores_gemma":[0.9799204,0.003686507,0.005007488,0.0006232858,0.002776801,0.00130172,0.0003488921,0.0003867116,0.005948175],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1671353,"threshold_uncertainty_score":0.9997699,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03211837541477341,"score_gpt":0.2926767589863165,"score_spread":0.2605583835715431,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}